Eagle Pharmaceuticals Inc (EGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 12-2012 | 09-2012 | 12-2011 | 09-2011 | |
| Sales | 13,679 | 0 | 2,539 | 2,539 | 2,539 |
| Cost of Goods | 7,381 | N/A | 3,166 | 3,166 | 3,166 |
| Gross Profit | 6,298 | -620 | -627 | -627 | -627 |
| Operating Expenses | 15,134 | 4,958 | 19,370 | 6,565 | 6,399 |
| Operating Income | -8,455 | -4,958 | -19,831 | -7,026 | -7,026 |
| Interest Expense | 309 | 0 | 91 | 91 | 91 |
| Other Income | 1,817 | 0 | -242 | -13,047 | -13,047 |
| Pre-tax Income | -6,947 | -4,958 | -20,164 | -20,164 | -20,164 |
| Income Tax | -899 | N/A | -781 | -781 | -781 |
| Net Income Continuous | -6,048 | -4,958 | -19,383 | -19,383 | -19,383 |
| Net Income | $-6,048 | $-6,048 | $-19,383 | $-19,383 | $-19,383 |
| EPS Basic Total Ops | -3.25 | N/A | -14.11 | N/A | N/A |
| EPS Basic Continuous Ops | -1.99 | N/A | -11.73 | N/A | N/A |
| EPS Diluted Total Ops | -3.25 | N/A | -14.11 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.99 | N/A | -11.73 | N/A | N/A |
| EBITDA(a) | $-7,133 | $-4,488 | $-19,354 | $-7,026 | $-7,026 |